Mainstream

Silexion Therapeutics Announces Exercise Of Warrants For $3.3m Gross Proceeds

Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds

Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds

Post ContentslxnRead More

You might also be interested in reading Solana Boosts Performance With 100% Uptime Record In Q2 2023.

January 29, 2025
In Mainstream